Literature DB >> 8582982

Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study.

L Fedele1, F Parazzini, L Luchini, R Mezzopane, L Tozzi, L Villa.   

Abstract

Frequency of recurrence of fibroids after myomectomy has been evaluated in 145 women (median age 38 years, range 21-52) who underwent myomectomy. After surgery all women returned for follow-up visit every 12 months after surgery. Transvaginal ultrasound examination was performed routinely in every patient at 24 and 60 months and at 12, 36 and 48 months if there were any abnormal pelvic findings or suspicious symptomatology. A total of 39 (27%) women gave birth after myomectomy. For the whole series, the cumulative probability of recurrence (CPR) increased constantly during the study period reaching 51% in 5 years. The 5-year CPR decreased with parity after myomectomy, being 55% for women with no childbirth after surgery and 42% (based on 13 recurrences, P < 0.01) for those who gave birth.

Entities:  

Mesh:

Year:  1995        PMID: 8582982     DOI: 10.1093/oxfordjournals.humrep.a136176

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

1.  Laparoscopic blockage of uterine artery and myomectomy: a new method of treating symptomatic uterine leiomyomas.

Authors:  Z Liang; H Xu; Y Chen; Y Li; Q Zhang
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

Review 2.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

3.  Effect of pregnancy on recurrence of symptomatic uterine myomas in women who underwent myomectomy.

Authors:  R T Aksoy; A Tokmak; A I Guzel; G Yildirim; M K Kokanali; M Doganay
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

4.  Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.

Authors:  Timothy I Richardson; Christian A Clarke; Kuo-Long Yu; Ying K Yee; Thomas J Bleisch; Jose E Lopez; Scott A Jones; Norman E Hughes; Brian S Muehl; Charles W Lugar; Terry L Moore; Pamela K Shetler; Richard W Zink; John J Osborne; Chahrzad Montrose-Rafizadeh; Nita Patel; Andrew G Geiser; Rachelle J Sells Galvin; Jeffrey A Dodge
Journal:  ACS Med Chem Lett       Date:  2010-12-09       Impact factor: 4.345

5.  Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.

Authors:  Fabio Ghezzi; Antonella Cromi; Valentino Bergamini; Stefano Scarperi; Pierfrancesco Bolis; Massimo Franchi
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

Review 6.  Interventions to reduce haemorrhage during myomectomy for fibroids.

Authors:  Eugene J Kongnyuy; Charles Shey Wiysonge
Journal:  Cochrane Database Syst Rev       Date:  2014-08-15

7.  Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy.

Authors:  Yasushi Kotani; Takako Tobiume; Risa Fujishima; Mamoru Shigeta; Hisamitsu Takaya; Hidekatsu Nakai; Ayako Suzuki; Isao Tsuji; Masaki Mandai; Noriomi Matsumura
Journal:  J Obstet Gynaecol Res       Date:  2017-12-11       Impact factor: 1.730

8.  Clinical predictors of successful vaginal myomectomy for prolapsed pedunculated uterine leiomyoma

Authors:  Serdar Aydın; Hale Göksever Çelik; Mustafa Maraşlı; Rabia Zehra Bakar
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-02-01

9.  Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus.

Authors:  Katherine J Kramer; Sarah Ottum; Damla Gonullu; Capricia Bell; Hanna Ozbeki; Jay M Berman; Maurice-Andre Recanati
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

10.  Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study.

Authors:  Kohei Nakamura; Kentaro Nakayama; Kaori Sanuki; Toshiko Minamoto; Tomoka Ishibashi; Emi Sato; Hitomi Yamashita; Masako Ishikawa; Satoru Kyo
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.